BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi G, Jiang H, Feng J, Zheng X, Zhang D, Jiang C, Zhang J. Aloe vera mitigates dextran sulfate sodium-induced rat ulcerative colitis by potentiating colon mucus barrier. J Ethnopharmacol 2021;279:114108. [PMID: 33839199 DOI: 10.1016/j.jep.2021.114108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang T, Liao J, Zheng L, Zhou Y, Jin Q, Wu Y. Aloe vera for prevention of radiation-induced dermatitis: A systematic review and cumulative analysis of randomized controlled trials. Front Pharmacol 2022;13:976698. [DOI: 10.3389/fphar.2022.976698] [Reference Citation Analysis]
2 Jiang H, Shi G, Fang Y, Liu Y, Wang Q, Zheng X, Zhang D, Zhang J, Yin Z. Aloin A prevents ulcerative colitis in mice by enhancing the intestinal barrier function via suppressing the Notch signaling pathway. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154403] [Reference Citation Analysis]
3 Ran B, Guo CE, Zhang Y, Han C, Cao T, Huang H, Geng Z, Li W. Preventive effect of Chinese dwarf cherry [Cerasus humilis (Bge.) Sok.] fermentation juice on dextran sulfate sodium-induced ulcerative colitis rats through the regulation of IgA and the intestinal immune barrier. Food Funct 2022;13:5766-81. [PMID: 35536119 DOI: 10.1039/d1fo04218a] [Reference Citation Analysis]
4 Che Q, Luo T, Shi J, He Y, Xu D. Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier. Front Cell Infect Microbiol 2022;12:863779. [DOI: 10.3389/fcimb.2022.863779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xu G, Xing G, Zhang B, Zhu J, Cai Y, Shen T, Rao J, Shi R, Cao Z, Nguyen T. The Relieving Effects of a Polyherb-Based Dietary Supplement ColonVita on Gastrointestinal Quality of Life Index (GIQLI) in Older Adults with Chronic Gastrointestinal Symptoms Are Influenced by Age and Cardiovascular Disease: A 12-Week Randomized Placebo-Controlled Trial. Evid Based Complement Alternat Med 2021;2021:6653550. [PMID: 34539805 DOI: 10.1155/2021/6653550] [Reference Citation Analysis]